RXT:NASDAQRackspace Technology, Inc. Analysis
Data as of 2026-06-23 - not real-time
$6.84
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $6.84, comfortably above its 20‑day ($5.49), 50‑day ($3.93) and 200‑day ($1.92) simple moving averages, indicating a strong uptrend. Momentum is reinforced by an RSI of 62, which sits in the upper‑mid range but remains below overbought levels. The MACD line sits above its signal line, generating a bullish histogram. Daily volume is rising, supporting the price advance. A beta of roughly 2.4 and a 30‑day volatility near 240% signal that price swings are amplified relative to the market.
Despite the technical strength, earnings are negative with a trailing EPS of –$0.61 and a forward PE of 131, underscoring weak profitability. The DCF‑derived fair value of about $1.00 is far below the current price, implying the market is pricing in a substantial premium. The upside/downside metric shows a –29% downside potential, further highlighting valuation concerns. Recent material news – a 30 MW AMD‑powered AI compute agreement, a new multi‑year cloud contract, and the opening of a regional headquarters in Riyadh – provide tangible growth catalysts for the hybrid‑cloud segment. However, the company carries over $3.2 bn of debt, a negative book value per share, and thin margins, which keep the long‑run risk elevated.
Despite the technical strength, earnings are negative with a trailing EPS of –$0.61 and a forward PE of 131, underscoring weak profitability. The DCF‑derived fair value of about $1.00 is far below the current price, implying the market is pricing in a substantial premium. The upside/downside metric shows a –29% downside potential, further highlighting valuation concerns. Recent material news – a 30 MW AMD‑powered AI compute agreement, a new multi‑year cloud contract, and the opening of a regional headquarters in Riyadh – provide tangible growth catalysts for the hybrid‑cloud segment. However, the company carries over $3.2 bn of debt, a negative book value per share, and thin margins, which keep the long‑run risk elevated.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (price above SMAs, MACD bullish)
- Increasing volume and positive news flow (AMD partnership, new cloud deal)
- Momentum supported by RSI in upper‑mid range
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued earnings weakness and high forward PE
- Elevated debt load and negative book value
- Valuation gap between price and DCF fair value
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Sustained profitability challenges
- Potential for overvaluation correction
- Sector volatility and high beta
Key Metrics & Analysis
Financial Health
Revenue Growth1.90%
Profit Margin-5.41%
P/E Ratio131.4
ROA-1.07%
P/B Ratio-1.4
Op. Cash Flow$143.9M
Free Cash Flow$235.7M
Industry P/E38.3
Technical Analysis
TrendBullish
RSI62.3
Support$3.91
Resistance$8.60
MA 20$5.49
MA 50$3.93
MA 200$1.92
MACDBullish
VolumeIncreasing
Fear & Greed Index86.16
Valuation
Fair Value$1.00
Target Price$4.83
Upside/Downside-29.29%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.39
Volatility239.99%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.